Story

Barclays Upgrades AkzoNobel and Arkema Amid Cautious Outlook for European Chemicals

ENTHMSVIIDZHZH-TWJAKOHI
Aug 12, 20262 min read
Barclays Upgrades AkzoNobel and Arkema Amid Cautious Outlook for European Chemicals
Text size
Background

Barclays has adopted a more selective stance on the European chemicals sector, upgrading AkzoNobel and Arkema while flagging potential headwinds for the second half of 2026. The bank's analysts now favor downstream specialty and defensive chemical companies, citing an uneven demand recovery and emerging macroeconomic risks.

A More Cautious Sector Stance

In a research note, analysts led by Katie Richards acknowledged that the second quarter delivered a "clear earnings recovery" for European chemical firms, with pricing turning positive year-over-year for the first time in three years. However, they cautioned that underlying demand trends remained mixed across different end-markets.

Barclays outlined several factors for its more cautious outlook, including:

  • Fading pricing support related to disruptions in the Middle East.
  • Re-emerging logistical risks tied to the Rhine river.
  • Softening leading economic indicators.
  • The sector trading near 18-month highs.

Given this backdrop, the bank stated a preference for "downstream specialty chemicals and defensive names such as Air Liquide," while maintaining an overall Negative stance on the European Chemicals & Ingredients sector.

Rating Upgrades

Sample IUX Markets – In-articleAd

Reflecting this strategic shift, Barclays upgraded AkzoNobel to Overweight from Equal Weight, raising its price target to €71 from €58. The analysts cited reduced uncertainty following the August 5 approval of the Axalta merger, an unrealized €600 million synergy target, a planned €2.5 billion special dividend, and improving fundamentals in its Automotive Refinish business.

Arkema was also upgraded to Equal Weight from Underweight, with its price target lifted to €56 from €51. The bank pointed to the company's improving capital allocation discipline and signs that construction markets, which represent about 40% of its end-market exposure, may have bottomed out.

Underweight Ratings Reiterated

Conversely, Barclays reiterated its Underweight ratings on several other major players. The bank noted that Lanxess and Solvay "carry some of the most demanding H2 recovery assumptions in the sector."

An Underweight rating was also maintained for BASF, with analysts highlighting less supportive petrochemical pricing and the company's exposure to cyclical and Rhine-related risks, despite what they described as relatively undemanding market expectations.

Read next

More on Stocks
Back to latest news

LATEST